Company Novo Integrated Sciences, Inc.

Equities

NVOS

US67011T3005

Healthcare Facilities & Services

Market Closed - Nasdaq 21:00:00 15/05/2024 BST 5-day change 1st Jan Change
0.537 USD -7.21% Intraday chart for Novo Integrated Sciences, Inc. -4.31% -34.59%

Business Summary

Novo Integrated Sciences, Inc. is a parent company to its subsidiaries. The Company owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.

Number of employees: 179

Sales per Business

USD in Million2022Weight2023Weight Delta
Healthcare Services
65.4 %
8 71.5 % 8 65.4 % -2.04%
Product
34.5 %
3 28.4 % 4 34.5 % +29.93%
Corporate
0.1 %
0 0.0 % 0 0.1 % +204.94%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
12 100.0 % 13 100.0 % +7.11%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 17/10/18
Director of Finance/CFO 38 06/07/23
President 60 02-14
Chief Tech/Sci/R&D Officer - 31/03/21
Chief Tech/Sci/R&D Officer - 23/06/21
Chief Operating Officer 65 12/08/14
Treasurer 43 14/03/18

Members of the board

Members of the board TitleAgeSince
Director/Board Member 43 25/01/21
Chief Operating Officer 65 12/08/14
Director/Board Member 42 29/06/22
Chief Executive Officer 56 17/10/18
Director/Board Member 49 25/01/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 19,054,523 17,755,470 ( 93.18 %) 0 93.18 %

Shareholders

NameEquities%Valuation
1,290,858 6.775 % 678 991 $
BlackRock Institutional Trust Co. NA
1.532 %
291,921 1.532 % 153 550 $
Vanguard Global Advisers LLC
1.310 %
249,632 1.310 % 131 306 $
Geode Capital Management LLC
0.6714 %
127,929 0.6714 % 67 291 $
Virtu Financial LLC
0.4524 %
86,197 0.4524 % 45 340 $
XTX Topco Ltd.
0.2089 %
39,807 0.2089 % 20 938 $
33,280 0.1747 % 17 505 $
Northern Trust Investments, Inc.(Investment Management)
0.1464 %
27,905 0.1464 % 14 678 $
G1 Execution Services LLC
0.0937 %
17,853 0.0937 % 9 391 $
Jane Street Group LLC
0.0847 %
16,132 0.0847 % 8 485 $

Company contact information

Novo Integrated Sciences, Inc.

11120 NE 2nd Street Suite 100

98004, Bellevue

+

http://novointegrated.com
address Novo Integrated Sciences, Inc.(NVOS)
  1. Stock Market
  2. Equities
  3. NVOS Stock
  4. Company Novo Integrated Sciences, Inc.